Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Gilead Q3 Profit Higher on Strong Flu Drug Royalties
TheStreet.com
Tuesday, October 20, 2009 - 5:01pm
tags:
Gilead Sciences, earnings
Pfizer will shut down Fort Dodge Animal Health’s Overland Park operations
Bizjournals.com
Tuesday, October 20, 2009 - 3:28pm
tags:
animal health, Pfizer, reorganization, Wyeth
Earnings Preview: Lilly
Seeking Alpha
Tuesday, October 20, 2009 - 3:27pm
tags:
earnings, Eli Lilly
[video] Sell Pfizer!: Against the Grain
TheStreet.com
Tuesday, October 20, 2009 - 10:37am
tags:
Pfizer
Amgen's Denosumab Delay Not a Deal-Breaker; Cancer Remains the Big Question
BNET Pharma
Tuesday, October 20, 2009 - 10:34am
tags:
Amgen, Prolia, FDA, osteoporosis, denosumab
Peregrine: Continuing to Accumulate on Any Dips
Seeking Alpha
Tuesday, October 20, 2009 - 10:34am
tags:
Peregrine Pharmaceuticals
Biogen Reports Higher Profit
TheStreet.com
Tuesday, October 20, 2009 - 10:19am
tags:
Biogen Idec, earnings
VaxGen: Full results show AIDS vaccine is of modest help
Yahoo/AP
Tuesday, October 20, 2009 - 10:17am
tags:
AIDS, HIV, vaccines, VaxGen
R&D deals drive a spike in M&A activity
Fierce Biotech
Tuesday, October 20, 2009 - 10:15am
tags:
R&D, M&A
Forest Labs profit skids 24 pct. after purchase of lung drug and settling Lexapro proceedings
Yahoo/AP
Tuesday, October 20, 2009 - 10:13am
tags:
Forest Labs, earnings, Nycomed, Lexapro
Merck in a post-blockbuster world
Fortune
Tuesday, October 20, 2009 - 10:02am
tags:
Merck, Schering Plough, M&A, reorganization, Pharma CEOs, Richard Clark
MorphoSys, Daiichi Sankyo Enter Alliance to Develop Antibodies
Bloomberg
Tuesday, October 20, 2009 - 9:07am
tags:
antibody discovery, MorphoSys, Daiichi Sankyo
How Many Jobs Has Pfizer Cut This Year?
WSJ Online
Tuesday, October 20, 2009 - 9:06am
tags:
Pfizer, layoffs
Human Genome, Glaxo: progress with lupus treatment
Marketwatch
Tuesday, October 20, 2009 - 7:56am
tags:
GSK, lupus, belimumab
Congresswoman: Deny Pfizer Any Federal Funding
Pharmalot
Tuesday, October 20, 2009 - 7:55am
tags:
Pfizer
Medco plans to compare Plavix, Effient in study
Yahoo/AP
Tuesday, October 20, 2009 - 7:42am
tags:
drug studies, Plavix, Effient, Medco, blood thinners
FDA approves GlaxoSmithKline renal cancer drug
Marketwatch
Tuesday, October 20, 2009 - 7:41am
tags:
GSK, renal cancer, FDA, Votrient
Pfizer Earnings Rise as Sales Fall 3%
TheStreet.com
Tuesday, October 20, 2009 - 7:40am
tags:
Pfizer, earnings
What Will Pfizer’s R&D Look Like a Year from Now?
WSJ Online
Monday, October 19, 2009 - 7:58pm
tags:
Pfizer, Wyeth, reorganization, R&D, M&A
GlaxoSmithKline's seasonal flu vaccine Fluarix approved for children
Yahoo/AP
Monday, October 19, 2009 - 7:56pm
tags:
GSK, vaccines, Flu, Fluarix

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.